Sat, Jan 31, 2015, 11:10 AM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

NovaBay Pharmaceuticals, Inc. Message Board

  • biobrainx biobrainx Nov 18, 2013 1:06 PM Flag

    The definition of INSANITY: Repeating the same thing and expecting the same result!!!

    The shorts thinking: I need this to go up so I can short more!
    The pumpers thinking: I need this to go up so I can make more money by buying/selling and SHORTING!!
    Those who believe them: IDIO@@@
    Please refresh my memory: NBY has no solid income anymore, just huge expense, is that right?
    The eye infections study by Alcon failed (NBY is REPEATING it!!), is that right?
    The impetigo study with GAlderma, the only paying partner, JUST FAILED?
    The market for the urinary blockage is very small, no partner?
    Shorts need high volume and too high for price (100000/day, $1.20)
    Bleach is being sold by CVS and it works, I don't think that a fancy version will be needed!!!

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • The definition of insanity: Repeating the same thing and expecting different results. Some bashers show insane tendencies. Have you been checked lately? Have you put bleach on your skin lately...........burns doesn't it.? Urinary blockage is a problem with market estimated at $200,000 to $500,000 for Nova..........not bad for a small company. You asume their new studies will fail even with improved formulas..........crazy way to invest before data provided in the new tests.........so once they fail--..they should not try again after investigating what went wrong?

      Sentiment: Hold

    • Up and Down, Up and Down!
      What happened to the huge sales predictions for any of these POS?
      Are you all ready for a FA!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!?

 
NBY
0.635+0.0200(+3.25%)Jan 30 4:01 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.